Arunjyoti Bio [ABVL] vs BLS International [BLS] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Arunjyoti Bio Ventures Ltd. wins in 3 metrics, BLS International Ltd. wins in 16 metrics, with 0 ties. BLS International Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Arunjyoti Bio Ventures Ltd. BLS International Ltd. Better
P/E Ratio (TTM) 55.46 18.13 BLS International Ltd.
Price-to-Book Ratio 4.38 5.47 Arunjyoti Bio Ventures Ltd.
Debt-to-Equity Ratio 71.24 16.55 BLS International Ltd.
PEG Ratio -0.53 0.52 BLS International Ltd.
EV/EBITDA 26.00 15.15 BLS International Ltd.
Profit Margin (TTM) -6.61% 22.39% BLS International Ltd.
Operating Margin (TTM) 8.92% 23.73% BLS International Ltd.
EBITDA Margin (TTM) 8.92% 23.73% BLS International Ltd.
Return on Equity -5.63% 25.17% BLS International Ltd.
Return on Assets (TTM) -3.06% 18.11% BLS International Ltd.
Free Cash Flow (TTM) $-44.22M $6.68B BLS International Ltd.
Dividend Yield N/A 1.11% N/A
1-Year Return -31.33% -35.83% Arunjyoti Bio Ventures Ltd.
Price-to-Sales Ratio (TTM) 6.11 4.05 BLS International Ltd.
Enterprise Value $1.56B $112.37B BLS International Ltd.
EV/Revenue Ratio 6.04 3.91 BLS International Ltd.
Gross Profit Margin (TTM) 100.00% 54.55% Arunjyoti Bio Ventures Ltd.
Revenue per Share (TTM) $1 $70 BLS International Ltd.
Earnings per Share (Diluted) $-0.09 $15.62 BLS International Ltd.
Beta (Stock Volatility) 0.21 -0.37 BLS International Ltd.

Arunjyoti Bio Ventures Ltd. vs BLS International Ltd. Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Arunjyoti Bio Ventures Ltd.-2.60%-3.75%-17.84%-32.54%-32.03%-34.98%
BLS International Ltd.0.46%1.43%-3.46%0.94%-16.84%-15.12%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Arunjyoti Bio Ventures Ltd.-31.33%-68.54%228.82%202.16%326.72%195.77%
BLS International Ltd.-35.83%40.99%732.75%1,096.79%1,096.79%1,096.79%

Performance & Financial Health Analysis: Arunjyoti Bio Ventures Ltd. vs BLS International Ltd.

MetricABVLBLS
Market Information
Market Cap i₹1.58B₹116.58B
Market Cap CategorySmall capMid cap
10 Day Avg. Volume i2,838,6342,407,744
90 Day Avg. Volume i1,898,8487,387,955
Last Close₹5.25₹270.40
52 Week Range₹5.05 - ₹12.71₹218.90 - ₹418.70
% from 52W High-58.69%-35.42%
All-Time High₹30.07 (Jan 15, 2024)₹521.80 (Dec 30, 2024)
% from All-Time High-82.54%-48.18%
Growth Metrics
Quarterly Revenue Growth0.05%0.44%
Quarterly Earnings Growth0.05%0.35%
Financial Health
Profit Margin (TTM) i-0.07%0.22%
Operating Margin (TTM) i0.09%0.24%
Return on Equity (TTM) i-0.06%0.25%
Debt to Equity (MRQ) i71.2416.55
Cash & Liquidity
Book Value per Share (MRQ)₹1.93₹51.78
Cash per Share (MRQ)₹0.01₹36.48
Operating Cash Flow (TTM) i₹-12,115,000₹6.30B
Levered Free Cash Flow (TTM) i₹-18,215,000₹5.08B
Dividends
Last 12-Month Dividend Yield iN/A1.11%
Last 12-Month Dividend iN/A₹3.00

Valuation & Enterprise Metrics Analysis: Arunjyoti Bio Ventures Ltd. vs BLS International Ltd.

MetricABVL (Apr 26, 2026)BLS (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i55.4618.13
Forward P/E iN/A14.60
PEG Ratio i-0.530.52
Price to Sales (TTM) i6.114.05
Price to Book (MRQ) i4.385.47
Market Capitalization
Market Capitalization i₹1.58B₹116.58B
Enterprise Value i₹1.56B₹112.37B
Enterprise Value Metrics
Enterprise to Revenue i6.043.91
Enterprise to EBITDA i26.0015.15
Risk & Other Metrics
Beta i0.21-0.37
Book Value per Share (MRQ) i₹1.93₹51.78

Financial Statements Comparison: Arunjyoti Bio Ventures Ltd. vs BLS International Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricABVL (2025)BLS (2025)
Revenue/Sales i278.84M21.93B
Cost of Goods Sold i114.29M9.86B
COGS % of Revenue i41.0%45.0%
Gross Profit i164.55M12.07B
Gross Margin i59.0%55.0%
Research & Development iN/AN/A
Operating Income (EBIT) i19.68M5.73B
Operating Margin i7.1%26.1%
EBITDA i52.95M7.05B
EBITDA Margin i19.0%32.2%
Pre-Tax Income i-3.41M6.06B
Pre-Tax Income % of Revenue i-1.2%27.6%
Income Tax i14.81M658.76M
Income Tax % of Revenue i5.3%3.0%
Net Income (Profit) i-18.22M5.40B
Profit Margin i-6.5%24.6%

Balance Sheet & Liquidity Metrics

MetricABVL (2025)BLS (2025)
Cash & Equivalents i5.92M2.82B
Total Current Assets i147.98M11.42B
Total Current Assets % of Revenue i53.1%52.1%
Total Current Liabilities i52.90M4.89B
Total Current Liabilities % of Revenue i19.0%22.3%
Long-Term Debt i214.50M2.84B
Long-Term Debt % of Revenue i76.9%13.0%
Total Shareholders Equity i323.80M20.19B
Retained Earnings i-30.59M12.49B
Retained Earnings % of Revenue i-11.0%56.9%
Property, Plant & Equipment i71.31M1.94B

Cash Flow Statement Comparison

MetricABVL (2025)BLS (2025)
Operating Cash Flow i-12.12M6.30B
Operating Cash Flow % of Revenue i-4.3%28.7%
Capital Expenditures i-58.72M-1.61B
Free Cash Flow i-44.22M6.68B
FCF Margin i-15.9%30.4%
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricABVLBLS
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i186.38M411.66M
Float Shares i11.37M116.81M
% Held by Insiders i68.86%73.11%
% Held by Institutions i0.00%5.55%
% Held by Public i31.14%21.34%

Dividend Analysis & Yield Comparison: Arunjyoti Bio Ventures Ltd. vs BLS International Ltd.

MetricABVLBLS
Last 12-Month Dividend iN/A₹3.00
Last 12-Month Dividend Yield iN/A1.11%
3-Year Avg Annual Dividend iN/A₹1.58
3-Year Avg Dividend Yield iN/A0.27%
3-Year Total Dividends iN/A₹4.75
Ex-Dividend DateN/AFeb 13, 2026